SEATTLE, Oct. 25 /PRNewswire-FirstCall/ -- ZymoGenetics, Inc. (Nasdaq: ZGEN) announced today that it will report third quarter 2007 financial results on Wednesday, October 31, 2007. Members of the company's senior management will discuss the results and provide a general corporate update in a conference call and webcast on Wednesday, October 31, 2007 at 10:30 a.m. Eastern Time.
The ZymoGenetics Q3 2007 Financial Results Conference Call may be accessed on October 31 by dialing 877-407-0782. The international dial in number is 201-689-8567. Participants should dial in to the call approximately 10 minutes prior to the scheduled start time to register. The webcast can be accessed at http://www.zymogenetics.com and will be archived for 30 days.
For replay, use the following information:
-- Replay number: 877-660-6853
-- International replay number: 201-612-7415
-- Replay passcodes (required for playback): account #: 286 and conference
ID #: 258415
ZymoGenetics creates novel protein drugs with the potential to significantly help patients fight their diseases. The Company is developing a diverse pipeline of product candidates that are moving into and through clinical development. These candidates span a wide array of clinical opportunities that include bleeding, autoimmune diseases and cancer. ZymoGenetics intends to commercialize these product candidates through internal development, collaborations with partners, and out-licensing of patents from its extensive patent portfolio. For further information, visit http://www.zymogenetics.com.
This press release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements are based on the current intent and expectations
of the management of ZymoGenetics
|SOURCE ZymoGenetics, Inc.|
Copyright©2007 PR Newswire.
All rights reserved